Isolation precautions for antibiotic-resistant bacteria in healthcare settings

Current Opinion in Infectious Diseases

Volumn 22, Issue 4, 2009, Pages 339-344

  Gasink, Leanne B ^a   Brennan, Patrick J ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Clostridium difficile; Drug resistance; Methicillin resistant staphylococcus aureus; Transmission; Vancomycin resistant enterococcus

Indexed keywords

ANTIBIOTIC RESISTANCE; BACTERIAL COLONIZATION; BACTERIUM IDENTIFICATION; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; DISEASE TRANSMISSION; HOSPITAL INFECTION; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PRACTICE GUIDELINE; REVIEW; STAPHYLOCOCCUS INFECTION;

BACTERIAL INFECTIONS; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HEALTH FACILITIES; HUMANS; INFECTION CONTROL; PATIENT ISOLATION;

EID: 67651090083     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0b013e32832d69b0     Document Type: Review

References (53)

1. Hidron AI, Edwards JR, Patel J, et al. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 2008; 29:996-1011. This 2006-2007 report describes the frequency of selected antimicrobial resistance patterns among pathogens causing device-associated and procedure-associated healthcare-associated infections reported by hospitals in the National Healthcare Safety Network.
2. Zilberberg MD, Shorr AF, Kollef MH. Increase in adult Clostridium difficile-related hospitalizations and case-fatality rate, United States, 2000-2005. Emerg Infect Dis 2008; 14:929-931.
3. Siegel JD, Rhinehart E, Jackson M, Chiarello L. Management of multidrug-resistant organisms in healthcare settings, 2006. Am J Infect Control 2007; 35 (10 Suppl 2):S165-S193.
4. Siegel JD, Rhinehart E, Jackson M, Chiarello L. 2007 Guideline for Isolation Precautions: preventing transmission of infectious agents in healthcare settings. Am J Infect Control 2007; 35 (10 Suppl 2):S65-S164.
5. Calfee DP, Salgado CD, Classen D, et al. Strategies to prevent transmission of methicillin-resistant Staphylococcus aureus in acute care hospitals. Infect Control Hosp Epidemiol 2008; 29 (Suppl 1):S62-S80. General guidelines for the prevention of MRSA included have part of a compendium of strategies to prevent healthcare-associated infections released by the Society for Healthcare Epidemiology of America.
6. Bearman GM, Marra AR, Sessler CN, et al. A controlled trial of universal gloving versus contact precautions for preventing the transmission of multi-drug-resistant organisms. Am J Infect Control 2007; 35:650-655.
7. Huang SS, Rifas-Shiman SL, Warren DK, et al. Improving methicillin-resistant Staphylococcus aureus surveillance and reporting in intensive care units. J Infect Dis 2007; 195:330-338.
8. Huang SS, Rifas-Shiman SL, Pottinger JM, et al. Improving the assessment of vancomycin-resistant enterococci by routine screening. J Infect Dis 2007; 195:339-346.
9. Weber SG, Huang SS, Oriola S, et al. Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: position statement from the Joint SHEA and APIC Task Force. Infect Control Hosp Epidemiol 2007; 28:249-260.
10. Fraser V, Murphy D, Brennan PJ, et al. Politically incorrect: legislation must not mandate specific healthcare epidemiology and infection prevention and control practices. Infect Control Hosp Epidemiol 2007; 28:594-595.
11. Farr BM. Political versus epidemiological correctness. Infect Control Hosp Epidemiol 2007; 28:589-593.
12. Association of Professionals in Infection Control (APIC). MRSA Law and Pending Legislation - 2009. Available from http://www.apic.org/am/images/maps/ mrsa-map.gif.
13. Morgan DJ, Diekema DJ, Sepkowitz K, Perencevich EN. Adverse outcomes associated with contact precautions: a review of the literature. Am J Infect Control 2009; 37:85-93. A systemic review of available literature regarding adverse outcomes associated with contact precautions.
14. Wenzel RP, Bearman G, Edmond MB. Screening for MRSA: a flawed hospital infection control intervention. Infect Control Hosp Epidemiol 2008; 29:1012-1018.
15. Milstone AM, Perl TM. Fact, fiction, or no data: what does surveillance for methicillin-resistant Staphylococcus aureus prevent in the intensive care unit? Clin Infect Dis 2008; 46:1726-1728.
16. Lautenbach E. Expanding the universe of methicillin-resistant Staphylococcus aureus prevention. Ann Intern Med 2008; 148:474-476.
17. Diekema DJ, Edmond MB. Look before you leap: active surveillance for multidrug-resistant organisms. Clin Infect Dis 2007; 44:1101-1107.
18. Diekema DJ, Climo M. Preventing MRSA infections: finding it is not enough. JAMA 2008; 299:1190-1192.
19. McGinigle KL, Gourlay ML, Buchanan IB. The use of active surveillance cultures in adult intensive care units to reduce methicillin-resistant Staphylococcus aureus-related morbidity, mortality, and costs: a systematic review. Clin Infect Dis 2008; 46:1717-1725.
20. Harbarth S, Fankhauser C, Schrenzel J, et al. Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. JAMA 2008; 299:1149-1157. This prospective controlled trial of active surveillance using PCR found no difference in MRSA during surveillance periods compared with control periods.
21. Robicsek A, Beaumont JL, Paule SM, et al. Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals. Ann Intern Med 2008; 148:409-418. This prospective observational cohort study of active surveillance using PCR found that active surveillance decreased MRSA when applied to all hospital admissions, but not when applied only in the ICU.
22. Kirkland K. Taking off the gloves: toward a less dogmatic approach to the use of contact isolation. Clin Infect Dis 2009; 48:766-771.
23. Jeyaratnam D, Whitty CJ, Phillips K, et al. Impact of rapid screening tests on acquisition of methicillin resistant Staphylococcus aureus: cluster randomised crossover trial. BMJ 2008; 336:927-930.
24. Uckay I, Sax H, Iten A, et al. Effect of screening for methicillin-resistant Staphylococcus aureus carriage by polymerase chain reaction on the duration of unnecessary preemptive contact isolation. Infect Control Hosp Epidemiol 2008; 29:1077-1079.
25. Conterno LO, Shymanski J, Ramotar K, et al. Impact and cost of infection control measures to reduce nosocomial transmission of extended-spectrum beta-lactamase-producing organisms in a nonoutbreak setting. J Hosp Infect 2007; 65:354-360.
26. Buhlmann M, Bogli-Stuber K, Droz S, Muhlemann K. Rapid screening for carriage of methicillin-resistant Staphylococcus aureus by PCR and associated costs. J Clin Microbiol 2008; 46:2151-2154.
27. Conterno LO, Shymanski J, Ramotar K, et al. Real-time polymerase chain reaction detection of methicillin-resistant Staphylococcus aureus: impact on nosocomial transmission and costs. Infect Control Hosp Epidemiol 2007; 28:1134-1141.
28. Mertz D, Frei R, Jaussi B, et al. Throat swabs are necessary to reliably detect carriers of Staphylococcus aureus. Clin Infect Dis 2007; 45:475-477.
29. Batra R, Eziefula AC, Wyncoll D, Edgeworth J. Throat and rectal swabs may have an important role in MRSA screening of critically ill patients. Intensive Care Med 2008; 34:1703-1706.
30. Evison J, Muhlemann K. Screening for carriage of methicillin-resistant Staphylococcus aureus shortly after exposure may lead to false-negative results. Infect Control Hosp Epidemiol 2008; 29:774-776.
31. Muto CA, Jernigan JA, Ostrowsky BE, et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus. Infect Control Hosp Epidemiol 2003; 24:362-386.
32. Cohen MJ, Adler A, Block C, et al. Acquisition of vancomycin-resistant enterococci in internal medicine wards. Am J Infect Control 2009; 37: 111-116.
33. Drees M, Snydman DR, Schmid CH, et al. Prior environmental contamination increases the risk of acquisition of vancomycin-resistant enterococci. Clin Infect Dis 2008; 46:678-685.
34. Calderwood MS, Mauer A, Tolentino J, et al. Epidemiology of vancomycin-resistant enterococci among patients on an adult stem cell transplant unit: observations from an active surveillance program. Infect Control Hosp Epidemiol 2008; 29:1019-1025.
35. West SK, Plantenga MS, Strausbaugh LJ. Use of decolonization to prevent staphylococcal infections in various healthcare settings: results of an Emerging Infections Network survey. Infect Control Hosp Epidemiol 2007; 28: 1111-1113.
36. Wendt C, Schinke S, Wurttemberger M, et al. Value of whole-body washing with chlorhexidine for the eradication of methicillin-resistant Staphylococcus aureus: a randomized, placebo-controlled, double-blind clinical trial. Infect Control Hosp Epidemiol 2007; 28:1036-1043.
37. Simor AE, Phillips E, McGeer A, et al. Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant Staphylococcus aureus colonization. Clin Infect Dis 2007; 44:178-185.
38. Jones JC, Rogers TJ, Brookmeyer P, et al. Mupirocin resistance in patients colonized with methicillin-resistant Staphylococcus aureus in a surgical intensive care unit. Clin Infect Dis 2007; 45:541-547.
39. Ammerlaan H, Kluytmans J, Wertheim H, et al. Eradication of methicillin-resistant Staphylococcus aureus carriage: a systemic review. Clin Infect Dis 2009; 48:922-930.
40. Gbaguidi-Haore H, Legast S, Thouverez M, et al. Ecological study of the effectiveness of isolation precautions in the management of hospitalized patients colonized or infected with Acinetobacter baumannii. Infect Control Hosp Epidemiol 2008; 29:1118-1123.
41. Harris AD, Perencevich EN, Johnson JK, et al. Patient-to-patient transmission is important in extended-spectrum beta-lactamase-producing Klebsiella pneumoniae acquisition. Clin Infect Dis 2007; 45:1347-1350.
42. Anderson B, Nicholas S, Sprague B, et al. Molecular and descriptive epidemiology of multidrug-resistant Enterobacteriaceae in hospitalized infants. Infect Control Hosp Epidemiol 2008; 29:250-255.
43. Maragakis LL, Tucker MG, Miller RG, et al. Incidence and prevalence of multidrug-resistant acinetobacter using targeted active surveillance cultures. JAMA 2008; 299:2513-2514.
44. Marchaim D, Navon-Venezia S, Schwartz D, et al. Surveillance cultures and duration of carriage of multidrug-resistant Acinetobacter baumannii. J Clin Microbiol 2007; 45:1551-1555.
45. Laurent C, Rodriguez-Villalobos H, Rost F, et al. Intensive care unit outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae controlled by cohorting patients and reinforcing infection control measures. Infect Control Hosp Epidemiol 2008; 29:517-524.
46. Reddy P, Malczynski M, Obias A, et al. Screening for extended-spectrum beta-lactamase-producing Enterobacteriaceae among high-risk patients and rates of subsequent bacteremia. Clin Infect Dis 2007; 45:846-852.
47. Dubberke ER, Reske KA, Olsen MA, et al. Evaluation of Clostridium difficile-associated disease pressure as a risk factor for C. difficile-associated disease. Arch Intern Med 2007; 167:1092-1097.
48. Gravel D, Gardam M, Taylor G, et al. Infection control practices related to Clostridium difficile infection in acute care hospitals in Canada. Am J Infect Control 2009; 37:9-14.
49. Muto CA, Blank MK, Marsh JW, et al. Control of an outbreak of infection with the hypervirulent Clostridium difficile BI strain in a university hospital using a comprehensive 'bundle' approach. Clin Infect Dis 2007; 45:1266-1273.
50. Weiss K, Boisvert A, Chagnon M, et al. Multipronged intervention strategy to control an outbreak of Clostridium difficile infection (CDI) and its impact on the rates of CDI from 2002 to 2007. Infect Control Hosp Epidemiol 2009; 30:156-162.
51. Whitaker J, Brown BS, Vidal S, Calcaterra M. Designing a protocol that eliminates Clostridium difficile: a collaborative venture. Am J Infect Control 2007; 35:310-314.
52. Gerding DN, Muto CA, Owens RC Jr. Measures to control and prevent Clostridium difficile infection. Clin Infect Dis 2008; 46 (Suppl 1):S43-S49.
53. Dubberke ER, Gerding DN, Classen D, et al. Strategies to prevent Clostridium difficile infections in acute care hospitals. Infect Control Hosp Epidemiol 2008; 29 (Suppl 1):S81-S92. Guidelines for prevention of C. difficile released by SHEA as part of a compendium of strategies to prevent healthcare-associated infections.